{
    "nctId": "NCT00072020",
    "briefTitle": "Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer",
    "officialTitle": "Does Adjuvant Zoledronic Acid Reduce Recurrence in Patients With High Risk Localized Breast Cancer?",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Metastatic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": "N/A",
    "primaryOutcomeMeasure": "Disease-free survival as assessed annually for 10 years",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Diagnosis of primary breast cancer, meeting 1 of the following staging criteria:\n\n  * Stage II\n  * Stage III\n  * T stage \u2265 T1\n* Receiving OR scheduled to receive chemotherapy and/or endocrine therapy\n\n  * For patients receiving neoadjuvant therapy\n\n    * Tumor \\> 5 cm (T3), features of locally advanced disease (T4), OR biopsy-proven lymph node involvement (N1)\n    * Scheduled to proceed to definitive surgery and/or radical radiotherapy with curative intent within 6 months of starting neoadjuvant therapy\n    * No more than 30 days between initiation of neoadjuvant therapy and start of study drug\n  * For patients receiving adjuvant therapy\n\n    * Must have undergone complete primary tumor resection and treatment of axillary lymph nodes\\*\n    * Must have lymph node involvement\n    * No prior neoadjuvant therapy\\*\\*\n    * No more than 60 days since prior definitive surgery NOTE: \\*Patients whose treatment plan includes further primary tumor resection and/or treatment of the axillary lymph nodes (e.g., clearance or radiotherapy) with curative intent after completion of chemotherapy are eligible provided the treatment is completed within 9 months of study entry\n\nNOTE: \\*\\*Preoperative endocrine therapy with a duration of \\< 30 days is not considered prior neoadjuvant therapy\n\n* No evidence of recurrent or metastatic disease\n* No history of breast cancer, except ductal carcinoma in situ or lobular carcinoma in situ\n* Hormone receptor status:\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\nAge\n\n* 18 and over\n\nSex\n\n* Female\n\nMenopausal status\n\n* Premenopausal or postmenopausal\n\nPerformance status\n\n* Karnofsky 80-100% OR\n* ECOG 0-1\n\nLife expectancy\n\n* Not specified\n\nHematopoietic\n\n* Not specified\n\nHepatic\n\n* Not specified\n\nRenal\n\n* Creatinine \u2264 1.5 times upper limit of normal\n\nOther\n\n* Not pregnant or nursing\n* Fertile patients must use effective contraception\n* No active dental problems, including dental abscess or infection of the jaw bone (e.g., maxilla or mandible)\n* No prior or current diagnosis of osteonecrosis of the jaw\n* No other malignancy within the past 5 years (including prior contralateral breast cancer) except nonmelanoma skin cancer or curatively treated carcinoma in situ of the cervix\n* No history of disease with influence on bone metabolism, including any of the following:\n\n  * Paget's disease of the bone\n  * Primary hyperparathyroidism\n  * Osteoporosis requiring treatment or likely to require treatment within the next 6 months\n* No other severe physical or psychological disease that would preclude study compliance\n* No known hypersensitivity to bisphosphonates\n\nPRIOR CONCURRENT THERAPY:\n\nChemotherapy\n\n* See Disease Characteristics\n\nEndocrine therapy\n\n* See Disease Characteristics\n\nRadiotherapy\n\n* See Disease Characteristics\n\nSurgery\n\n* See Disease Characteristics\n* More than 4 weeks since prior and no concurrent dental or jaw surgery (e.g., extractions or implants)\n\n  * Dental fillings, teeth scaling and polishing, or minor gingival surgery within the past 4 weeks are allowed\n\nOther\n\n* More than 1 year since prior bisphosphonates\n* More than 30 days since prior investigational drugs\n* No concurrent investigational drugs (i.e., not locally approved for any indication)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}